“The transaction would create a merged company that is uniquely vertically integrated across multiple levels of the pharmacy supply chain. This new business model for the pharmacy sector could raise barriers to rivals expanding or entering, which may lessen competition,” said ACC Commissioner Stephe Ridgeway.
Competition regulator outlines "preliminary competition concerns" on CW-Sigma merger
June 13, 2024 Latest NewsBioPharmaNews of the Day![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/dd1dd2a64d7e7ccd4afc00965648ead5.png)
Latest Video
New Stories
-
AbbVie announces new leadership for its New Zealand business
June 24, 2024 - - Latest News -
Report suggests significant funding boost for Pharmac
June 24, 2024 - - Latest News -
Joint submission recommends adjustments to minimum stockholding requirement
June 24, 2024 - - Latest News -
A legally questionable outcome but one that reveals the truth of this process
June 23, 2024 - - Latest News -
Oncology leadership transitions for MSD Australia and New Zealand
June 23, 2024 - - Latest News -
The 'Week in Review' Podcast - 21 June
June 21, 2024 - - Podcast -
MSD managing director departing to lead the company's Japan oncology business
June 21, 2024 - - Latest News